The Prevention of Biochemical Changes in Lens, Retina, and Nerve of Galactosemic Dogs by the Aldose Reductase Inhibitor AL01576.

Autor: LOU, MARJORIE F., DICKERSON, JAIME E., CHANDLER, MICHAEL L., BRAZZELL, R. KIM, YORK, BILLIE M.

Publikováno v: Journal of Ocular Pharmacology; 1989, Vol. 5 Issue 3, p233-240, 8p

Dose-Dependent Pharmacokinetics of the Aldose Reductase Inhibitor Imirestat in Man

Autor: Brazzell, R. Kim, Mayer, Philip R., Dobbs, Richard, McNamara, Patrick J., Teng, Renli, Slattery, John T.

Publikováno v: Pharmaceutical Research; January 1991, Vol. 8 Issue: 1 p112-118, 7p

Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.

Autor: Kim T; Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA., Sall K; Sall Research Medical Center, Inc, Artesia, CA, USA., Holland EJ; Department of Ophthalmology, Cincinnati Eye Institute, University of Cincinnati, Cincinnati, OH, USA., Brazzell RK; Kala Pharmaceuticals, Inc, Waltham, MA, USA, kim.brazzell@kalarx.com., Coultas S; Kala Pharmaceuticals, Inc, Waltham, MA, USA, kim.brazzell@kalarx.com., Gupta PK; Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2018 Dec 27; Vol. 13, pp. 69-86. Date of Electronic Publication: 2018 Dec 27 (Print Publication: 2019).